indazoles has been researched along with Nervous System Disorders in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pal, D; Sahu, P | 1 |
| Cheng, CY; Liu, T; Mruk, DD; Shao, J; Silvestrini, B; Wang, B; Xia, W; Xie, QR; Ying, W; Yu, H; Zhang, T | 1 |
1 review(s) available for indazoles and Nervous System Disorders
| Article | Year |
|---|---|
Importance of Indazole against Neurological Disorders.
Topics: Glycogen Synthase Kinase 3; Humans; Indazoles; Monoamine Oxidase; Nervous System Diseases; Parkinson Disease; Structure-Activity Relationship | 2022 |
1 other study(ies) available for indazoles and Nervous System Disorders
| Article | Year |
|---|---|
Adjudin attenuates lipopolysaccharide (LPS)- and ischemia-induced microglial activation.
Topics: Analysis of Variance; Animals; Anti-Inflammatory Agents; Brain Edema; Brain Infarction; CD11b Antigen; Cell Line, Transformed; Cell Survival; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Interactions; Hydrazines; Indazoles; Infarction, Middle Cerebral Artery; Lipopolysaccharides; Male; Mice; Mice, Inbred ICR; Microglia; Nervous System Diseases; NF-kappa B; Psychomotor Performance; Signal Transduction; Time Factors | 2013 |